Is the Sexual Function Compromised in Long-Term Testicular Cancer Survivors?

European Urology

Volumn 52, Issue 5, 2007, Pages 1438-1447

  Dahl, Alv A ^a   Bremnes, Roy ^b   Dahl, Olav ^c   Klepp, Olbjørn ^d   Wist, Erik ^e   Fosså, Sophie D ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brief Sexual Function Inventory; Long term survivors; Sexual functioning; Testicular cancer

Indexed keywords

CISPLATIN;

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EJACULATION; FOLLOW UP; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; NORWAY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOM SAMPLE; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; SOCIAL ASPECT; TESTIS CANCER;

ADULT; CROSS-SECTIONAL STUDIES; EJACULATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEXUALITY; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 34548856770     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.02.046     Document Type: Article

References (27)

1. Albers P., Albrect W., Algaba F., et al. Guidelines on testicular cancer. Eur Urol 48 (2005) 885-894
2. Albers P. Management of stage I testis cancer. Eur Urol 51 (2007) 34-43
3. Jonker-Pool G., Van de Wiel H.B.M., Hoekstra H.J., et al. Sexual functioning after treatment for testicular cancer-review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behavior 30 (2001) 55-74
4. Nazareth I., Lewin J., and King M. Sexual dysfunction after treatment for testicular cancer. A systematic review. J Psychosom Res 51 (2001) 735-743
5. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
6. O'Leary M.P., Fowler F.J., Lenderking W.R., et al. A brief male sexual function inventory for urology. Urology 46 (1995) 697-706
7. O'Leary M.P., Rhodes T., Girman C.J., et al. Distribution of the Brief Male Sexual Inventory in community men. Int J Impotence Res 15 (2003) 185-191
8. Mykletun A., Dahl A.A., O'Leary M., et al. Male sexual function: normative data based on the general population. Br J Urology 97 (2006) 316-323
9. Dahl A.A., Haaland C.F., Mykletun A., et al. Study of anxiety and depression in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 2389-2395
10. Mykletun A., Dahl A.A., Haaland C.F., et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 23 (2005) 3061-3068
11. Fosså S.D., Horwich A., Russell J.I.M., et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council (UK) randomised trial. J Clin Oncol 17 (1999) 1146-1154
12. Fosså S.D., Klepp O., Ous S., et al. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumour in clinical stage I. Eur Urol 10 (1984) 17-23
13. Dolven Jacobsen K., Ous S., Wæhre H., et al. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br. J Cancer 80 (1999) 249-255
14. Oldenburg J., Fosså S.D., and Dahl A.A. Scale for Chemotherapy-induced Long-term Neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 15 (2006) 791-800
15. Aasland O.G., Amundsen A., Bovim G., et al. Identification of patients at risk of alcohol related damage [article in Norwegian]. Tidsskr Nor Laegeforen 110 (1990) 1523-1527
16. Thorsen L., Nystad W., Stigum H., et al. The association between self-reported physical activity and prevalence of depression and anxiety in long-term survivors of testicular cancer and in general population sample. Support Care Cancer 13 (2005) 637-646
17. Nord C., Bjøro T., Ellingsen D., et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 44 (2003) 322-328
18. Bjelland I., Dahl A.A., Tangen Haug T., et al. The validity of The Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52 (2002) 69-77
19. Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J Psychosom Res 37 (1993) 147-153
20. Sloan J.A., Vargas-Chanas, Kamath C.C., et al. Detecting worms, ducks, and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. J Cancer Med 1 (2003) 41-47
21. Schwartz C., Sprangers M., and Fayers P. Response shift: you know it's there but how do you capture it? Challenges for the next phase of research. In: Fayers P., and Hays R. (Eds). Assessing quality of life in clinical trials. 2nd ed. (2005), Oxford University Press, Oxford 275-290
22. Williams S.D., Birch R., Einhorn L.H., et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316 (1987) 1435-1440
23. Sogaard A.J., Selmer R., Bjertness E., et al. The Oslo Health Study: the impact of self-selection in a large, population-based survey. Int J Equity Health 3 (2004) 3
24. Selmer R., Sogaard A.J., Bjertness E., et al. The Oslo Health study: reminding the non-responders-effects on prevalence estimates. Norsk Epidemiol 13 (2003) 89-94
25. Stigum H., Magnus P., Veierod M., et al. Impact on sexually transmitted disease spread of increased condom use by young females, 1987-1992. Int J Epidemiol 24 (1995) 813-820
26. Stigum H., Magnus P., Harris J.R., et al. Frequency of sexual partner change in a Norwegian population. Data distribution and covariates. Am J Epidemiol 145 (1997) 636-643
27. Hamilton L., Kulseng Berg A., Træen B., et al. Self-reported frequency of feeling sexual desire among a representative sample of 18-49 year old men and women in Oslo, elucidated by epidemiological data. Scand J Sexol 4 (2001) 25-41